INTERNATIONAL BIOTECHNOLOGY TRUST PLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2019$2,181,000
-29.3%
96,0000.0%0.81%
-29.0%
Q1 2019$3,087,000
+45.4%
96,0000.0%1.14%
-13.4%
Q4 2018$2,123,000
-14.0%
96,000
-14.3%
1.32%
+12.3%
Q3 2018$2,469,000
-41.1%
112,0000.0%1.17%
-27.1%
Q2 2018$4,189,000
+188.5%
112,000
+202.7%
1.61%
+184.3%
Q1 2018$1,452,00037,0000.57%
Other shareholders
INTERSECT ENT INC shareholders Q2 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders